ALNYLAM PHARMACEUTICALS, INC. 4
4 · ALNYLAM PHARMACEUTICALS, INC. · Filed Dec 22, 2015
Insider Transaction Report
Form 4
Gros David-Alexandre C
SVP, Chief Business Officer
Transactions
- Award
Stock Option (right to buy)
2015-12-18+15,012→ 15,012 totalExercise: $88.95Exp: 2025-12-18→ Common Stock (15,012 underlying)
Footnotes (1)
- [F1]The stock option vests as to 25% of the shares on the 1st anniversary of the date of the stock option grant and as to an additional 6.25% of the shares each successive three month period thereafter.